Selma Ugurel Selected Research

dimemorfan (AT 17)

1/2021

Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Selma Ugurel Research Topics

Disease

107	Melanoma (Melanoma, Malignant) 03/2024 - 08/2002
74	Neoplasms (Cancer) 05/2024 - 01/2003
22	Skin Neoplasms (Skin Cancer) 12/2023 - 03/2007
20	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2003
20	Merkel Cell Carcinoma 12/2023 - 05/2006
9	Disease Progression 01/2023 - 08/2002
6	Brain Neoplasms (Brain Tumor) 01/2023 - 09/2008
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2022 - 03/2007
4	Uveal melanoma 10/2023 - 06/2003
3	Carcinoma (Carcinomatosis) 05/2024 - 11/2020
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 07/2006
3	Dermatofibrosarcoma 01/2017 - 03/2007
2	COVID-19 01/2023 - 01/2022
2	Glioma (Gliomas) 12/2022 - 11/2022
2	Encephalitis (Encephalitis, Rasmussen) 12/2022 - 11/2022
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 10/2020
2	Myasthenia Gravis 03/2021 - 01/2019
2	Inflammation (Inflammations) 01/2021 - 01/2021
2	Fibrosis (Cirrhosis) 01/2021 - 01/2014
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2014 - 07/2010
1	Carcinogenesis 04/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023
1	Lymphadenopathy 05/2023
1	Lymphatic Metastasis 05/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023
1	Leukocytosis (Pleocytosis) 11/2022
1	Nevus (Nevi) 11/2022
1	Necrosis 01/2022
1	Cardiotoxicity 01/2022
1	Cytokine Release Syndrome 10/2021

Drug/Important Bio-Agent (IBA)

51	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2016
22	Biomarkers (Surrogate Marker)IBA 10/2023 - 08/2002
17	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2024 - 02/2007
17	NivolumabIBA 12/2023 - 01/2016
16	IpilimumabIBA 12/2023 - 11/2016
12	pembrolizumabIBA 04/2022 - 01/2016
10	Phosphotransferases (Kinase)IBA 01/2023 - 08/2004
10	AntibodiesIBA 11/2022 - 05/2008
8	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 07/2005
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2005
6	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 03/2007
5	Programmed Cell Death 1 ReceptorIBA 01/2023 - 01/2017
5	Adenosine Triphosphate (ATP)IBA 09/2017 - 01/2003
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 01/2021
4	VemurafenibIBA 01/2021 - 01/2014
4	ParaffinIBA 07/2017 - 04/2007
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 07/2023 - 01/2017
3	cyclopropapyrroloindoleIBA 01/2023 - 01/2021
3	Messenger RNA (mRNA)IBA 11/2022 - 01/2014
3	avelumabIBA 11/2022 - 07/2021
3	AntigensIBA 06/2021 - 06/2004
3	Monoclonal AntibodiesIBA 01/2020 - 07/2016
3	InterferonsIBA 01/2020 - 09/2008
3	Dacarbazine (DIC)FDA LinkGeneric 09/2017 - 09/2008
3	Formaldehyde (Formol)FDA Link 07/2017 - 01/2014
3	Histocompatibility Antigens Class IIBA 01/2017 - 06/2004
3	Indicators and Reagents (Reagents)IBA 08/2009 - 08/2002
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 01/2021
2	Interleukin-17 (Interleukin 17)IBA 09/2023 - 01/2023
2	VaccinesIBA 05/2023 - 11/2012
2	InterleukinsIBA 01/2023 - 01/2023
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 03/2006
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2022
2	Leucine (L-Leucine)FDA Link 12/2022 - 11/2022
2	trametinibIBA 01/2022 - 01/2018
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2020 - 01/2020
2	Histone Deacetylases (Histone Deacetylase)IBA 06/2019 - 02/2006
2	dabrafenibIBA 01/2018 - 01/2014
2	denileukin diftitox (Ontak)FDA Link 01/2014 - 07/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2013 - 03/2012
2	LigandsIBA 02/2013 - 08/2009
2	Peptides (Polypeptides)IBA 11/2012 - 06/2007
2	Tumor Biomarkers (Tumor Markers)IBA 07/2009 - 12/2005
2	Drug CombinationsIBA 09/2006 - 06/2003
2	HLA-DR Antigens (HLA-DR)IBA 06/2004 - 08/2002
1	Viral ProteinsIBA 04/2024
1	COVID-19 VaccinesIBA 05/2023
1	Dimethyl FumarateIBA 01/2023
1	Monomeric GTP-Binding ProteinsIBA 01/2023
1	CytokinesIBA 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	apremilastIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 11/2022
1	S 27IBA 08/2022
1	Peptide Receptors (Peptide Receptor)IBA 03/2022
1	Radioisotopes (Radionuclides)IBA 03/2022
1	Deoxyglucose (2 Deoxy D glucose)IBA 02/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	encorafenibIBA 10/2021
1	binimetinibIBA 10/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2021
1	TransferasesIBA 10/2021

Therapy/Procedure

84	Therapeutics 05/2024 - 08/2002
20	Immunotherapy 04/2024 - 05/2008
13	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
7	Radiotherapy 03/2022 - 04/2007
5	Aftercare (After-Treatment) 05/2024 - 04/2007
2	Combination Drug Therapy (Combination Chemotherapy) 09/2017 - 04/2007
2	Palliative Care (Palliative Therapy) 06/2008 - 01/2007
1	Immunomodulation 01/2023